Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

342
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
342

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter Study.

Neurology·2026
Same author

Neuropsychological functioning in clinically referred patients with sarcoidosis: a preliminary investigation.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2026
Same author

Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Early Versus Delayed Treatment with Ocrelizumab: A Multicenter, Real-World Observational Study in People with Multiple Sclerosis.

Neurology and therapy·2026
Same author

Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis.

Drugs·2026
Same author

Flip angle in susceptibility-weighted imaging for the diagnosis of multiple sclerosis - Authors' reply.

The Lancet. Neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
Same journal

Functional movement disorders: diagnosis, pathophysiology, and treatment.

Current opinion in neurology·2026
Same journal

Galectins in the brain: advances in neuroinflammation, neuroprotection and therapeutic opportunities: Erratum.

Current opinion in neurology·2026
查看所有相关文章

相关实验视频

Updated: May 15, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.7K

重新定义多发性硬化症的进展.

Jeffrey Lambe1, Daniel Ontaneda

  • 1Mellen Center for Multiple Sclerosis Treatment and Research, Neurology Department, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA.

Current opinion in neurology
|April 8, 2025
PubMed
概括
此摘要是机器生成的。

多发性硬化症 (MS) 的进展很早就开始,由炎症和神经退行驱动. 识别这些早期的渐进性成分对于复发性复发性多发性硬化症 (RRMS) 的个性化治疗策略至关重要.

关键词:
临床试验是指临床试验中的临床试验.多发性硬化症多发性硬化症神经退行症的神经退行症神经炎症是一种神经炎症.这是一个渐进的过程.

更多相关视频

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

10.9K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.3K

相关实验视频

Last Updated: May 15, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.7K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

10.9K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.3K

科学领域:

  • 神经学 神经学
  • 免疫学 免疫学 免疫学
  • 病理学 病理学 病理学

背景情况:

  • 多发性硬化症 (MS) 是一种慢性自身免疫性疾病,影响中枢神经系统.
  • 临床过程定义正在发展,包括在复发的同时进行进展.

研究的目的:

  • 审查多发性硬化症 (MS) 的进展情况.
  • 确定驱动多发性硬化症进展的病理机制.
  • 提供MS早期渐进性生物学的证据.

主要方法:

  • 对有关MS进展的现有文献的审查.
  • 对病理机制的分析.
  • 检查临床试验数据,包括托莱布鲁替尼.

主要成果:

  • 独立于复发的进展对复发性复发性多发性硬化症 (RRMS) 的残疾有显著的贡献.
  • 多发性硬化症的进展包括炎症,微质激活,氧化应激和神经退行.
  • 这些病理过程在疾病的早期就很明显,并且随着时间的推移而演变.

结论:

  • 多发性硬化症的进展是一个连续的过程,可以在RRMS早期检测到.
  • 疾病进展的病理驱动因素与残疾相关.
  • 个性化治疗策略需要早期识别使用临床措施和生物标志物的渐进性成分.